SEARCH

SEARCH BY CITATION

References

  • Andresen MC, Kunze DL (1994). Nucleus tractus solitarius–gateway to neural circulatory control. Annu Rev Physiol 56: 93116.
  • Andrews P, Torii Y, Saito H, Matsuki N (1996). The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus. Eur J Pharmacol 307: 305313.
  • Andrews PL, Davis CJ, Bingham S, Davidson HI, Hawthorn J, Maskell L (1990). The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 68: 325345.
  • Andrews PL, Horn CC (2006). Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Auton Neurosci 125: 100115.
  • Andrews PLR, Rudd JA (2004). The role of tachykinins and the tachykinin NK1 receptor in nausea and emesis. In: HolzerP (ed). Handbook of Experimental Pharmacology. Springer: Berlin, Germany. pp. 359440.
  • Axelsson P, Thorn SE, Lovqvist A, Wattwil L, Wattwil M (2006). Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine. Can J Anaesth 53: 370374.
  • Axelsson P, Thorn SE, Wattwil M (2004). Betamethasone does not prevent nausea and vomiting induced by ipecacuanha. Acta Anaesthesiol Scand 48: 12831286.
  • Bargmann CI (1998). Neurobiology of the Caenorhabditis elegans genome. Science 282: 20282033.
  • Bargmann CI, Hartwieg E, Horvitz HR (1993). Odorant-selective genes and neurons mediate olfaction in C. elegans. Cell 74: 515527.
  • Bertrand PP (2006). Real-time measurement of serotonin release and motility in guinea pig ileum. J Physiol 577: 689704.
  • Billig I, Yates BJ, Rinaman L (2001). Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin. Am J Physiol Regul Integr Comp Physiol 281: R12431255.
  • Borison HL (1959). Effect of ablation of medullary emetic chemoreceptor trigger zone on vomiting responses to cerebral intraventricular injection of adrenaline, apomorphine and pilocarpine in the cat. J Physiol 147: 172177.
  • Borison HL, Hebertson LM (1959). Role of medullary emetic chemoreceptor trigger zone (CT zone) in postnephrectomy vomiting in dogs. Am J Physiol 197: 850852.
  • Borsook D, Becerra LR (2006). Breaking down the barriers: fMRI applications in pain, analgesia and analgesics. Mol Pain 2: 30.
  • Bradner WT, Schurig JE (1981). Toxicology screening in small animals. Cancer Treat Rev 8: 93102.
  • Brizzee KR, Neal LM, Williams PM (1955). The chemoreceptor trigger zone for emesis in the monkey. Am J Physiol 180: 659662.
  • Burdyga G, Varro A, Dimaline R, Thompson DG, Dockray GJ (2006). Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. Am J Physiol Gastrointest Liver Physiol 290: G12891297.
  • Butcher WJ, Kasparov S, Paton FJ (1999). Differential effects of apamin on neuronal excitability in the nucleus tractus solitarii of rats studied in vitro. J Auton Nerv Syst 77: 9097.
  • Caras SD, Soykan I, Beverly V, Lin Z, McCallum RW (1997). The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects. Neurogastroenterol Motil 9: 151156.
  • Castillo EJ, Delgado-Aros S, Camilleri M, Burton D, Stephens D, O'Connor-Semmes R, Walker A, Shachoy-Clark A, Zinsmeister AR (2004). Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 287: G363369.
  • Chapman K, Pullen N, Graham M, Ragan I (2007). Preclinical safety testing of monoclonal antibodies: the significance of species relevance. Nat Rev Drug Discov 6: 120126.
  • Chen MC, Wu SV, Reeve JR, Jr., Rozengurt E (2006). Bitter stimuli induce Ca2+ signaling and CCK release in enteroendocrine STC-1 cells: role of L-type voltage-sensitive Ca2+ channels. Am J Physiol Cell Physiol 291: C726739.
  • Christie DA, Tansey EM (2007). The discovery, use and impact of platinum salts as chemotherapy agents for cancer: The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 4 April 2006. Wellcome Trust: London. p. 148.
  • Colbert HA, Bargmann CI (1995). Odorant-specific adaptation pathways generate olfactory plasticity in C. elegans. Neuron 14: 803812.
  • Conte C, Guarin E, Marcuz A, Andres-Barquin PJ (2006). Functional expression of mammalian bitter taste receptors in Caenorhabditis elegans. Biochimie 88: 801806.
  • Corcoran ML, Fox RA, Daunton NG (1990). The susceptibility of rhesus monkeys to motion sickness. Aviat Space Environ Med 61: 807809.
  • Costall B, Domeney AM, Naylor RJ (1986). A model of nausea and emesis in the common marmoset. Br J Pharmacol 88: 375.
  • Costall B, Naylor J, Owera-Atepo J, Tattersall F (1989). The responsiveness of the ferret to apomorphine-induced emesis. Br J Pharmacol 96: 329P.
  • Cote B, Frenette R, Prescott S, Blouin M, Brideau C, Ducharme Y, Friesen RW, Laliberte F, Masson P, Styhler A, Girard Y (2003). Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors. Bioorg Med Chem Lett 13: 741744.
  • Cummings DE, Overduin J (2007). Gastrointestinal regulation of food intake. J Clin Invest 117: 1323.
  • Cushing H (1931). I. The Reaction to Posterior Pituitary Extract (Pituitrin) When Introduced into the Cerebral Ventricles. Proc Natl Acad Sci USA 17: 163170.
  • Darmani NA, Zhao W, Ahmad B (1999). The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew). J Neural Transm 106: 10451061.
  • Daunton NG (1990). Animal Models in Motion Sickness Research. In: CramptonGH (ed). Motion and Space Sickness. CRC Press: Boca Raton, USA. pp. 87104.
  • Davis CJ (1995). Emesis research: a concise history of the critical concepts and experiments. In: ReynoldsDJM, AndrewsPLR, DavisCJ (eds). Serotonin and the scientific basis of anti-emetic therapy. Oxford Clinical Communications: Oxford. pp. 924.
  • De Lartigue G, Dimaline R, Varro A, Dockray GJ (2007). Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J Neurosci 27: 28762882.
  • Faas H, Feinle C, Enck P, Grundy D, Boesiger P (2001). Modulation of gastric motor activity by a centrally acting stimulus, circular vection, in humans. Am J Physiol Gastrointest Liver Physiol 280: G850857.
  • Fauser AA, Fellhauer M, Hoffmann M, Link H, Schlimok G, Gralla RJ (1999). Guidelines for anti-emetic therapy: acute emesis. Eur J Cancer 35: 361370.
  • Fukuda H, Koga T, Furukawa N, Nakamura E, Shiroshita Y (1998). The tachykinin NK1 receptor antagonist GR205171 prevents vagal stimulation-induced retching but not neuronal transmission from emetic vagal afferents to solitary nucleus neurons in dogs. Brain Res 802: 221231.
  • Fukuda H, Koga T, Furukawa N, Nakamura E, Hatano M, Yanagihara M (2003). The site of antiemetic action of NK1 receptor. In: DonnerJ (ed). Antiemetic Therapy. Karger: Basel. pp. 3377.
  • Fukui H, Yamamoto M (1999). Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy. Eur J Pharmacol 372: 261267.
  • Furukawa T, Yamada K (1980). The alpha-naphthoxyacetic acid-elicited retching involves dopaminergic inhibition in mice. Pharmacol Biochem Behav 12: 735738.
  • Gandara DR, Harvey WH, Monaghan GG, Perez EA, Hesketh PJ (1993). Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo. Eur J Cancer 29A (Suppl. 1): S3538.
  • Golding JF, Gresty MA (2005). Motion sickness. Curr Opin Neurol 18: 2934.
  • Golding JF, Stott JR (1997). Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. J Clin Pharmacol 43: 633637.
  • Gross PM, Wall KM, Pang JJ, Shaver SW, Wainman DS (1990). Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am J Physiol 259: R11311138.
  • Gunther EC, Stone DJ, Gerwien RW, Bento P, Heyes MP (2003). Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci USA 100: 96089613.
  • Gylys JA, Gidda JA (1986). Radiation induced emesis in ferrets: An experimental model of emesis. Gastroenterology 90: 1446.
  • Hall G, Symonds M (2006). Overshadowing and latent inhibition of context aversion conditioning in the rat. Auton Neurosci 129: 4249.
  • Hammas B, Hvarfner A, Thorn SE, Wattwil M (1998a). Effects of propofol on ipecacuanha-induced nausea and vomiting. Acta Anaesthesiol Scand 42: 447451.
  • Hammas B, Hvarfner A, Thorn SE, Wattwil M (1998b). Propofol sedation and gastric emptying in volunteers. Acta Anaesthesiol Scand 42: 102105.
  • Harding RK (1995). 5-HT3 receptor antagonists and radiation-induced emesis: preclinical data. In: ReynoldsDJM, AndrewsPLR, DavisCJ (eds). Serotonin and the scientific basis of anti-emetic therapy. Oxfrod Clinical Communications: Oxford. pp. 127133.
  • Harding RK, Hugenholtz H, Kucharczyk J, Lemoine J (1987). Central mechanisms for apomorphine-induced emesis in the dog. Eur J Pharmacol 144: 6165.
  • Harrison AP, Erlwanger KH, Elbrond VS, Andersen NK, Unmack MA (2004). Gastrointestinal-tract models and techniques for use in safety pharmacology. J Pharmacol Toxicol Methods 49: 187199.
  • Hesketh PJ (2008). Chemotherapy-induced nausea and vomiting. N Engl J Med 358: 24822494.
  • Hilliard MA, Bergamasco C, Arbucci S, Plasterk RH, Bazzicalupo P (2004). Worms taste bitter: ASH neurons, QUI-1, GPA-3 and ODR-3 mediate quinine avoidance in Caenorhabditis elegans. Embo J 23: 11011111.
  • Ho KY, Gan TJ (2006). Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Curr Opin Anaesthesiol 19: 606611.
  • Hoffmann IS, Roa M, Torrico F, Cubeddu LX (2003). Ondansetron and metformin-induced gastrointestinal side effects. Am J Ther 10: 447451.
  • Horn CC, Ciucci M, Chaudhury A (2007). Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness. Auton Neurosci 132: 4451.
  • Horn CC, Richardson EJ, Andrews PL, Friedman MI (2004). Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin. Auton Neurosci 115: 7481.
  • Hornby PJ (2001). Central neurocircuitry associated with emesis. Am J Med 111 (Suppl. 8A): 106S112S.
  • Isaacs B (1956). The influence of hyoscine and atropine on apomorphine-induced vomiting in man. Clin Sci (Lond) 15: 177182.
  • Isaacs B, Macarthur JG (1954). Influence of chlorpromazine and promethazine on vomiting induced with apomorphine in man. Lancet 267: 570572.
  • Isobe Y, Kurimoto A, Tobe M, Hashimoto K, Nakamura T, Norimura K, Ogita H, Takaku H (2006). Synthesis and biological evaluation of novel 9-substituted-8-hydroxyadenine derivatives as potent interferon inducers. J Med Chem 49: 20882095.
  • Ji J, Bunnelle WH, Anderson DJ, Faltynek C, Dyhring T, Ahring PK, Rueter LE, Curzon P, Buckley MJ, Marsh KC, Kempf-Grote A, Meyer MD (2007). A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models. Biochem Pharmacol 74: 12531262.
  • Kasparov S, Paton JF (1999). Differential effects of angiotensin II in the nucleus tractus solitarii of the rat–plausible neuronal mechanism. J Physiol 521 Pt 1: 227238.
  • Kasper S, Fuger J, Moller HJ (1992). Comparative efficacy of antidepressants. Drugs 43 (Suppl. 2): 1122; discussion 22–3.
  • Kimmel AR, Parent CA (2003). The signal to move: D. discoideum go orienteering. Science 300: 15251527.
  • King GL (1988). Characterization of radiation-induced emesis in the ferret. Radiat Res 114: 599612.
  • Klein RL, Militello TE, Ballinger CM (1968). Antiemetic effect of metoclopramide… evaluation in humans. Anesth Analg 47: 259264.
  • Koch KL, Stern RM, Vasey MW, Seaton JF, Demers LM, Harrison TS (1990a). Neuroendocrine and gastric myoelectrical responses to illusory self-motion in humans. Am J Physiol 258: E304310.
  • Koch KL, Summy-Long J, Bingaman S, Sperry N, Stern RM (1990b). Vasopressin and oxytocin responses to illusory self-motion and nausea in man. J Clin Endocrinol Metab 71: 12691275.
  • Kowalski A, Rapps N, Enck P (2006). Functional cortical imaging of nausea and vomiting: a possible approach. Auton Neurosci 129: 2835.
  • Kraus T, Hosl K, Kiess O, Schanze A, Kornhuber J, Forster C (2007). BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm 114: 14851493.
  • Kris MG, Cubeddu LX, Gralla RJ, Cupissol D, Tyson LB, Venkatraman E, Homesley HD (1996). Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin. Cancer 78: 21932198.
  • Kris MG, Gralla RJ, Clark RA, Tyson LB, O'Connell JP, Wertheim MS, Kelsen DP (1985). Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 3: 13791384.
  • Laffan RJ, Borison HL (1957). Emetic action of nicotine and lobeline. J Pharmacol Exp Ther 121: 468476.
  • Lang IM, Sarna SK, Shaker R (1999). Gastrointestinal motor and myoelectric correlates of motion sickness. Am J Physiol 277: G642652.
  • Langley CK, Aziz Q, Bountra C, Gordon N, Hawkins P, Jones A, Langley G, Nurmikko T, Tracey I (2008). Volunteer studies in pain research–opportunities and challenges to replace animal experiments: the report and recommendations of a Focus on Alternatives workshop. Neuroimage 42: 467473.
  • Lee A (2007). Adverse drug reactions. 2nd edn. Pharmaceutical Press: London.
  • Lehmann A, Karrberg L (1996). Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret. Neuropharmacology 35: 475481.
  • Leslie RA (1986). Comparative aspects of the area postrema: fine-structural considerations help to determine its function. Cell Mol Neurobiol 6: 95120.
  • Leslie RA, Reynolds DJM (1993). Neurotransminers and receptors in the emetic pathway. In: AndrewsPLR, SangerGJ (eds). Emesis in Anti-Cancer Therapy: Mechanisms and Treatment. Chapman and Hall Medical: London. p. 91.
  • Light RU, Bysshe SM (1933). The administration of drugs into the cerebral ventricles of monkeys: pituitrin, certain pituitary fractions, pitressin, pitocin, histamine, acetyl scholine, and pilocarpine. J Pharmacol Exp Ther 47: 1736.
  • Lindquist N, Hay ME (1995). Can small rare prey be chemically defended? The case for marine larvae. Ecology 76: 13471358.
  • Liu YL, Malik N, Sanger GJ, Friedman MI, Andrews PL (2005). Pica–a model of nausea? Species differences in response to cisplatin. Physiol Behav 85: 271277.
  • Loewy AD (1990). Central autonomic pathways. In: LoewyAD, SpyerKM (eds). Central regulations of autonomic functions. Oxford University Press: New York. pp. 88103.
  • Mantovani G, Maccio A, Esu S, Lai P (1996). Evidence that cisplatin induces serotonin release from human peripheral blood mononuclear cells and that methylprednisolone inhibits this effect. Eur J Cancer 32A: 19831985.
  • Martin M (1996). The severity and pattern of emesis following different cytotoxic agents. Oncology 53 Suppl 1: 2631.
  • Mayer J (2007). Use of behavior analysis to recognize pain in small mammals. Lab Anim (NY) 36: 4348.
  • McClellan AD (1983). Higher order neurons in buccal ganglia of Pleurobranchaea elicit vomiting motor activity. J Neurophysiol 50: 658670.
  • Milano S, Blower P, Romain D, Grelot L (1995). The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis. J Pharmacol Exp Ther 274: 951961.
  • Miller AD, Rowley HA, Roberts TP, Kucharczyk J (1996). Human cortical activity during vestibular- and drug-induced nausea detected using MSI. Ann N Y Acad Sci 781: 670672.
  • Minthorn E, Mencken T, King AG, Shu A, Rominger D, Gontarek RR, Han C, Bambal R, Davis CB (2008). Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret. Drug Metab Dispos 36: 18461852.
  • Minton N, Swift R, Lawlor C, Mant T, Henry J (1993). Ipecacuanha-induced emesis: a human model for testing antiemetic drug activity. Clin Pharmacol Ther 54: 5357.
  • Minton NA (1994). Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists. Br J Clin Pharmacol 37: 525530.
  • Morest DK (1960). A study of the structure of the area postrema with Golgi methods. Am J Anat 107: 291303.
  • Nagakura Y, Kakimoto S, Matsuoka N (2007). Purinergic P2X receptor activation induces emetic responses in ferrets and Suncus murinus (house musk shrews). Br J Pharmacol 152: 464470.
  • Narayanan JT, Watts R, Haddad N, Labar DR, Li PM, Filippi CG (2002). Cerebral activation during vagus nerve stimulation: a functional MR study. Epilepsia 43: 15091514.
  • Nauck MA, Meier JJ (2005). Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. Regul Pept 128: 135148.
  • Nemoto M, Endo T, Minami M, Yoshioka M, Ito H, Saito H (2001). 5-Hydroxytryptamine (5-HT)-induced depolarization in isolated abdominal vagus nerves in the rat: involvement of 5-HT3 and 5-HT4 receptors. Res Commun Mol Pathol Pharmacol 109: 217230.
  • Niemegeers CJ (1982). Antiemetic specificity of dopamine antagonists. Psychopharmacology (Berl) 78: 210213.
  • Niemegeers CJ (1971). The apomorphine antagonism test in dogs. Experimental evidence and critical considerations on specific methodological criteria. Pharmacology 6: 353364.
  • Nussey SS, Hawthorn J, Page SR, Ang VT, Jenkins JS (1988). Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha. Clin Endocrinol (Oxf) 28: 297304.
  • Nuttley WM, Atkinson-Leadbetter KP, Van Der Kooy D (2002). Serotonin mediates food-odor associative learning in the nematode Caenorhabditis elegans. Proc Natl Acad Sci USA 99: 1244912454.
  • Onishi T, Mori T, Yanagihara M, Furukawa N, Fukuda H (2007). Similarities of the neuronal circuit for the induction of fictive vomiting between ferrets and dogs. Auton Neurosci 136: 2030.
  • Osuide G, Adejoh PO (1973). Effects of apomorphine and its interaction with other drugs in the domestic fowl. Eur J Pharmacol 23: 5666.
  • Parker LA, Limebeer CL (2006). Conditioned gaping in rats: a selective measure of nausea. Auton Neurosci 129: 3641.
  • Parrott RF, Ebenezer IS, Baldwin BA, Forsling ML (1991). Hormonal effects of apomorphine and cholecystokinin in pigs: modification of the response to cholecystokinin by a dopamine antagonist (metoclopramide) and a kappa opioid agonist (PD117302). Acta Endocrinol (Copenh) 125: 420426.
  • Pavlov IP (1960). Conditioned reflexes; an investigation of the physiological activity of the cerebral cortex. Dover Publications: New York.
  • Pelchat ML, Rozin P (1982). The special role of nausea in the acquisition of food dislikes by humans. Appetite 3: 341351.
  • Percie Du Sert N, Andrews PLR (2007). Systematic review of the ferret model of cisplatin-induced emesis. In: 6th World congress on Alternatives and Animal Use in the Life Sciences. Japanese Society for Alternatives to Animal Experiments: Hotel East 21, Tokyo, Japan.
  • Percie Du Sert N, Rudd JA, Andrews PLR (2007). Simultaneous telemetric recording of electrogastrogram (EGG) and emesis in the ferret. Neurogastroenterol Motil 19; Suppl 3: 39.
  • Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J (2006). Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. Jama 295: 761775.
  • Pickering M, Jones JF (2002). The diaphragm: two physiological muscles in one. J Anat 201: 305312.
  • Pradel E, Zhang Y, Pujol N, Matsuyama T, Bargmann CI, Ewbank JJ (2007). Detection and avoidance of a natural product from the pathogenic bacterium Serratia marcescens by Caenorhabditis elegans. Proc Natl Acad Sci USA 104: 22952300.
  • Proctor JD, Chremos AN, Evans EF, Wasserman AJ (1978). An apomorphine-induced vomiting model for antiemetic studies in man. J Clin Pharmacol 18: 9599.
  • Reid K, Palmer JL, Wright RJ, Clemes SA, Troakes C, Somal HS, House F, Stott JR (2000). Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man. Br J Clin Pharmacol 50: 6164.
  • Rizk AN, Hesketh PJ (1999). Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development. Drugs R D 2: 229235.
  • Robichaud A, Savoie C, Stamatiou PB, Tattersall FD, Chan CC (2001). PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway. Neuropharmacology 40: 262269.
  • Rudd JA, Andrews PL (2004). Mechanisms of acute, delayed and anticipatory vomiting in cancer and cancer treatment. In: HeskethP (ed). Management of nausea and vomiting in cancer and cancer treatment. Jones and Barlett Publishers Inc.: New York. pp. 1566.
  • Rudd JA, Jordan CC, Naylor RJ (1994). Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis. Eur J Pharmacol 262: R12.
  • Rudd JA, Naylor JR (1995). Opioid receptor involvement in emesis and antiemesis. In: ReynoldsDJM, AndrewsPLR, DavisCJ (eds). Serotonin and the Scientific Basis of Anti-Emetic Therapy. Clinical Communications: Oxford. pp. 208221.
  • Russell WMS, Burch RL (1959). The principles of humane experimental technique. Methuen & Co Ltd.: London.
  • Sanger GJ, Andrews PL (2006). Treatment of nausea and vomiting: gaps in our knowledge. Auton Neurosci 129: 316.
  • Saxena PN, Chawla N, Johri MB, Iqbal S (1977). Nature of receptors involved in apomorphine responses in pigeons. Psychopharmacology (Berl) 53: 8995.
  • Schein PS, Davis RD, Carter S, Newman J, Schein DR, Rall DP (1970). The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man. Clin Pharmacol Ther 11: 340.
  • Share NN, Chai CY, Wang SC (1965). Emesis Induced by Intracerebroventricular Injections of Apomorphine and Deslanoside in Normal and Chemoreceptive Trigger Zone Ablated Dogs. J Pharmacol Exp Ther 147: 416421.
  • Shields KG, Ballinger CM, Hathaway BN (1971). Antiemetic effectiveness of haloperidol in human volunteers challenged with apomorphine. Anesth Analg 50: 10171024.
  • Shishido Y, Wakabayashi H, Koike H, Ueno N, Nukui S, Yamagishi T, Murata Y, Naganeo F, Mizutani M, Shimada K, Fujiwara Y, Sakakibara A, Suga O, Kusano R, Ueda S, Kanai Y, Tsuchiya M, Satake K (2008). Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist ‘CJ-17,493. Bioorg Med Chem 16: 71937205.
  • Smith JA, Jennings M (2004). Categorising the severity of scientific procedures on animals: Summary and reports from three round-table discussions http://www.boyd-group.demon.co.uk/.
  • Smith JE, Paton JF, Andrews PL (2002). An arterially perfused decerebrate preparation of Suncus murinus (house musk shrew) for the study of emesis and swallowing. Exp Physiol 87: 563574.
  • Spina D (2008). PDE4 inhibitors: current status. Br J Pharmacol 155: 308315.
  • Sternini C (2007). Taste receptors in the gastrointestinal tract. IV. Functional implications of bitter taste receptors in gastrointestinal chemosensing. Am J Physiol Gastrointest Liver Physiol 292: G457461.
  • Tajima T, Takiguchi N, Kato J, Ikeda T, Kuroda A, Ohtake H (2003). Mutants of the nematode Caenorhabditis elegans that are defective specifically in their attraction to cycloheximide. J Biosci Bioeng 96: 149153.
  • Tajima T, Watanabe N, Kogawa Y, Takiguchi N, Kato J, Ikeda T, Kuroda A, Ohtake H (2001). Chemotaxis of the nematode Caenorhabditis elegans toward cycloheximide and quinine hydrochloride. J Biosci Bioeng 91: 322324.
  • Takeda N, Hasegawa S, Morita M, Matsunaga T (1993). Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol Biochem Behav 45: 817821.
  • Tanihata S, Igarashi H, Suzuki M, Uchiyama T (2000). Cisplatin-induced early and delayed emesis in the pigeon. Br J Pharmacol 130: 132138.
  • Teng MS, Dekkers MP, Ng BL, Rademakers S, Jansen G, Fraser AG, McCafferty J (2006). Expression of mammalian GPCRs in C. elegans generates novel behavioural responses to human ligands. BMC Biol 4: 22.
  • Tiersch TR, Griffith JS (1988). Apomorphine-induced vomiting in rainbow trout (Salmo gairdneri). Comp Biochem Physiol A 91: 721725.
  • Tuor UI, Kondysar MH, Harding RK (1988). Emesis, radiation exposure, and local cerebral blood flow in the ferret. Radiat Res 114: 537549.
  • Ueno S, Matsuki N, Saito H (1987). Suncus murinus: a new experimental model in emesis research. Life Sci 41: 513518.
  • Van Oudenhove L, Coen SJ, Aziz Q (2007). Functional brain imaging of gastrointestinal sensation in health and disease. World J Gastroenterol 13: 34383445.
  • Van Sickle MD, Oland LD, Ho W, Hillard CJ, Mackie K, Davison JS, Sharkey KA (2001). Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology 121: 767774.
  • Verbalis JG, Richardson DW, Stricker EM (1987). Vasopressin release in response to nausea-producing agents and cholecystokinin in monkeys. Am J Physiol 252: R749753.
  • Wang Y, Lavond DG, Chambers KC (1997). The effects of cooling the area postrema of male rats on conditioned taste aversions induced by LiC1 and apomorphine. Behav Brain Res 82: 149158.
  • Watanabe Y, Okamoto M, Ishii T, Takatsuka S, Taniguchi H, Nagasaki M, Saito A (2008). Long-lasting anti-emetic effect of T-2328, a novel NK(1) antagonist. J Pharmacol Sci 107: 151158.
  • Watson JW, Gonsalves SF, Fossa AA, McLean S, Seeger T, Obach S, Andrews PL (1995). The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor. Br J Pharmacol 115: 8494.
  • Williams RS, Boeckeler K, Graf R, Muller-Taubenberger A, Li Z, Isberg RR, Wessels D, Soll DR, Alexander H, Alexander S (2006). Towards a molecular understanding of human diseases using Dictyostelium discoideum. Trends Mol Med 12: 415424.
  • Wu SV, Rozengurt N, Yang M, Young SH, Sinnett-Smith J, Rozengurt E (2002). Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells. Proc Natl Acad Sci USA 99: 23922397.
  • Xie L, Wang J, Bourne PE (2007). In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators. PLoS Comput Biol 3: e217.
  • Yamakuni H, Sawai H, Maeda Y, Imazumi K, Sakuma H, Matsuo M, Mutoh S, Seki J (2000). Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs. J Pharmacol Exp Ther 292: 10021007.
  • Yates BJ, Miller AD, Lucot JB (1998). Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 47: 395406.
  • Zhang Y, Hang L, Bargmann CI (2005). Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans. Nature 438: 179184.